# A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil

> **NCT07199946** · PHASE1,PHASE2 · RECRUITING · sponsor: **Johnny Ludvigsson** · enrollment: 36 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Verapamil (Part A)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07199946
- **Lead sponsor:** Johnny Ludvigsson
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-06
- **Primary completion:** 2029-12
- **Final completion:** 2030-05
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199946, "A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07199946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*